HIV Prevention Drug May Lower Genital Herpes Risk
But effect isn't strong enough to make it a stand-alone preventive treatment for herpes, expert says
Those results aren't strong enough to warrant the use of tenofovir alone or in combination solely for herpes prevention, according to Cohen. He added that tenofovir "is not designed to reduce herpes acquisition."
So why does it matter if tenofovir prevents genital herpes? Because it's a very common infection and can pave the way for other medical problems.
"About 20 percent of adults in the U.S. have genital herpes infection, and about 50 percent of adults in Africa," study lead author Celum said. "Previous studies have indicated that genital herpes increases the risk of becoming HIV-infected by about two-fold."
The cost of the tenofovir combination drug is about $100 a year in Africa and $1,000 per month in the United States, she said.
The next step for research is to determine if tenofovir can provide protection against HIV and herpes when administered through vaginal and rectal gel and in a vaginal ring, she said. Researchers also want to know if the drug can prevent people with HIV from getting herpes.
As for cold sores -- herpes simplex virus 1 -- she said tenofovir may have an effect on it, too. Previous research using tenofovir in a vaginal gel reduced the risk of both herpes simplex 1 and 2.
The study is in the July 1 issue of the Annals of Internal Medicine.